HighTower Advisors’s Merck MRK Stock Holding History

HighTower Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4,000	Closed	-$5.46K	–	3974
2025 Q2	$5.46K	Buy	4,000 +3,500	+700%	+$278K	﹤0.01%	3671
2025 Q1	$1.42K	Sell	500 -4,500	-90%	-$420K	﹤0.01%	3641
2024 Q4	$2.08K	Buy	5,000 +4,600	+1,150%	+$474K	﹤0.01%	3681
2024 Q3	$439	Buy	+400	New	+$47.5K	﹤0.01%	3691
2022 Q2	–	Sell	-2	Closed	-$1K	–	3434
2022 Q1	$1K	Buy	+2	New	+$158	﹤0.01%	3369
2021 Q3	–	Sell	-2,000	Closed	-$6K	–	3339
2021 Q2	$6K	Buy	+2,000	New	+$149K	﹤0.01%	3026
2020 Q4	–	Sell	-3,878	Closed	-$3K	–	2745
2020 Q3	$3K	Buy	3,878 +3,668	+1,747%	+$287K	﹤0.01%	2487
2020 Q2	$1K	Buy	+210	New	+$15.8K	﹤0.01%	2409
2018 Q3	–	Sell	-4,192	Closed	-$6K	–	2374
2018 Q2	$6K	Buy	+4,192	New	+$236K	﹤0.01%	2170
2014 Q2	–	Sell	-524	Closed	-$4K	–	1673
2014 Q1	$4K	Buy	+524	New	+$27.1K	﹤0.01%	1543

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HighTower Advisors's MRK Position: Q1 2026 in Review

HighTower Advisors reduced its Merck (MRK) stake by 4.8% in Q1 2026, selling an estimated $21.1M and leaving 3,635,404 shares worth $437M. The position accounts for 0.46% of the portfolio, ranked #33.

HighTower Advisors first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

HighTower Advisors held 3,635,404 shares of Merck worth $437M as of Q1 2026.
HighTower Advisors sold 182,731 Merck shares in Q1 2026, an estimated $21.1M.
Merck made up 0.46% of HighTower Advisors's portfolio in Q1 2026, its #33 holding.
HighTower Advisors first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.